NCT07523269Recruiting
WEARABLE-BP: Wearable Everyday Automated Readings to Enable Assessment of Blood Pressure Control
Source: ClinicalTrials.gov · Last updated 13 Apr 2026
Brief summary (registry, in English)
The WEARABLE-BP study will evaluate the clinical value of obtaining continual measurements using the Aktiia G1 Optical Blood Pressure Monitoring (OBPM) device in hypertensive patients, compared to using a traditional upper arm cuff for home BP monitoring. The WEARABLE-BP study aims to compare the change in unattended automated office blood pressure from baseline to 6 months between two study groups: those given an Aktiia G1 BP monitor and those given a traditional upper arm BP cuff.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 164 (estimated)
- First submitted
- 30 Mar 2026
- Start date
- Apr 2026
- Primary completion date
- Sept 2027
- Lead sponsor
- Aktiia SA
- Diseases
- High blood pressure
- NCT number
- NCT07523269
What you commit to
- Study type: Interventional
- Planned participants: 164
- From Apr 2026 to the primary completion date, Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe hypertension (SBP \> 180 mmHg or DBP \> 120 mmHg).
- Known severe valvular heart disease.
- Known resting heart rate \> 120 bpm.
- Known Raynaud's disease.
- Known tremors or shivering disorders.
- Known exfoliative skin diseases.
- Known allergy to silicone.
- Presence of implanted devices, such as a pacemaker, defibrillator, intravascular device, or arteriovenous fistula.
Lab values
- Known severe heart failure (LVEF \< 35%).
- Known severe chronic kidney disease (CKD stage 4-5; eGFR \< 30 mL/min/1.73 m²).
- Known severe diabetes (Hemoglobin A1c \> 10%).
Other
- Pregnant or breastfeeding.
- Known pheochromocytoma.
- Known uncontrolled hyperthyroidism or hypothyroidism.
- Known persistent atrial fibrillation.
- Presence of lymphedema.
- Paralysis of the arm.
- Arm amputation.
- Upper arm circumference \< 22 cm or \> 42 cm.
- Wrist circumference \> 23 cm.
- Mastectomy
Who the study is looking for
- Adults aged 21 to 85 years.
- Able to read and speak English.
- Have an MGB provider and medical record number in EPIC
- Study participants will wear the Aktiia bracelet for 6 months
- Willing to attend two on-site study visits and comply with all study procedures.
- Signed informed consent provided.
- Own a smartphone with iOS or Android operating system.
- Hypertensive with uncontrolled systolic blood pressure (SBP) \>135 mm Hg by unattended automated office measurement
- Currently taking 0, 1 or 2 antihypertensive medications.
Age in the registry: 21 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mass General Brigham Hospital Coordinator of this site? Confirm its status | Boston | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.